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PREGNANCY RATES IN BEEF CATTLE AFTER ADMINISTRATION
OF GnRH AGONIST 11 TO 14 DAYS AFTER INSEMINATION
I. Rettmer, J. S. Stevenson, and L. R. Corah1
Summary
Pregnancy rates were assessed in suckled
beef cows (n=145) and virgin beef heifers
(n=606) of mixed breeding following an
injection of either 100 or 200 µg of a GnRH
agonist given once on d 11-14 after estrus and
insemination.  In heifers, the 100 µg dose
improved (P<.08) pregnancy rates, based on
rectal palpation of the uterus, and at both doses,
based on actual calving dates.  There was no
effect of either dose on pregnancy rates of
suckled cows, based on palpation results, but
actual calving showed a 21% increase (P<.08)
in pregnancy rates in cows treated with 100 µg
of the GnRH agonist.
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 Introduction
Several studies have indicated improved
pregnancy rates in cattle treated during the
postinsemination period with various potent
gonadotropin-releasing hormone (GnRH)
agonists (analogs that mimic the biological
effects of the parent compound).  GnRH is a
naturally  occurring  decapeptide  (protein)  
composed of amino acids and produced by the
hypothalamus in the brain. Hypothalamic GnRH
causes the release of the gonadotropins,
luteinizing hormone (LH) and follicle-
stimulating hormone (FSH), from the pituitary
gland. Currently, two GnRH products are on the
market: Cystorelin® (gonadorelin diacetate
tetrahydrate), available from SANOFI Animal
Health Inc., Overland Park, KS (formally
known as CEVA Laboratories, Inc.); and
Factrel® (gonadorelin hydrochloride) produced
by Fort Dodge Laboratories, Fort Dodge, IA.
These two GnRH products are similar to the
naturally occurring GnRH and have nearly equal
potency.
Several new GnRH agonists (currently
available for experimental use) are more potent
(2.5 to 10 times) in their ability to release LH
and FSH.  One of these agonists is fertirelin
acetate (marketed outside the U.S. as Ovalyse®),
available from The Upjohn Company,
Kalamazoo, MI.
The objectives of our study were to
determine the dose-pregnancy rate effect of
fertirelin acetate in a multi-location field study,




Suckled cows (n=162) at two locations and
virgin heifers (n=606) at five locations were
inseminated at a synchronized estrus.  Estrus
was synchronized in heifers by feeding .5 mg
melengestrol acetate (MGA) for 14 d and then
injecting (i.m.) 25 mg Lutalyse® 17 d after the
last daily feeding of MGA.  Suckled cows were
given one injection (i.m.) of Lutalyse to regress
the corpus luteum and induce estrus in those
cows that were cycling.  Cows and heifers were
inseminated 6-12 h after estrus was observed.
Cows were of mixed breeding across locations,
including purebred and crosses of Angus,
Hereford, Simmental, and Salers.
Once heifers and cows were inseminated,
they were allotted, based on inseminator and
sire of breeding, into blocks and assigned
randomly to receive (i.v.) either 100 or 200 µg
of a GnRH analog agonist (fertirelin acetate in
4 ml of saline) or a control dose of 4 ml saline.
Injections of the GnRH agonist were given once
on d 11-14 after estrus (d 0 = estrus).  Heifers
and cows were exposed to clean-up bulls or re-
inseminated after the initial artificial
insemination and subsequent treatment.
Pregnancy was verified by palpation of the
uterus per rectum between 45 and 80 d after
insemination and(or) by actual calving dates at
two of five locations of heifers and at both
locations of cows.  Blood was collected from all
females at treatment.  Those with concentrations
of progesterone in serum < 1 ng/ml were
excluded from analyses, because we assumed
that they were not in their luteal phase at the
time of GnRH treatment.
Results and Discussion
Results for heifers at five locations are
summarized in  Table 1.   There appeared to 
be a pregnancy rate response to the agonist in
heifers at four of the locations (locations 1, 2, 4,
and 5), based on palpation results.  Based on
actual calving dates at two locations, both doses
of the GnRH agonist appeared to increase
pregnancy rates.  The 100 µg dose increased
(P<.08) pregnancy rates beyond that of the
control.  However, based on fewer actual
calvings, the effect of the GnRH agonist at both
doses tended (P<.11) to improve fertility.
Results of the experiment for suckled cows
at two locations are summarized in Table 2.
There was no effect of either dose, based on the
palpation results, but 100 µg of the GnRH
agonist increased (P<.08) pregnancy rates,
based on calving.
The difference in the results between
pregnancy rates by palpation and those obtained
by actual calvings can be accounted for by the
difficulty in differentiating ages of fetuses that
were 15 to 20 d apart.  This difficulty mainly
occurred when palpations were performed at d
70 to 80 after insemination, particularly at one
location of heifers and at one location of cows,
when differentiating between fetuses of 70-80
days of age and those of 50-60 days of age.
These results provide good preliminary
evidence and that administering a GnRH agonist
to virgin heifers and suckled cows during the
luteal phase (d 11 to 14) after insemination
increases pregnancy rates.  Other work indicates
that the mode of action is the ability of the
GnRH agonist to luteinize ovarian follicles or in
some way alter follicular function at this stage
of the estrous cycle or pregnancy, thereby
rendering follicles non-estrogenic and delaying
the luteolytic process for several days, sufficient
to increase the probability of pregnancy in some
females.
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Table 1. Pregnancy Rates (%) in Virgin Beef Heifers Based on Palpation of the Uterus (45
to 80 d) and Actual Calving Dates1
Location
Dose, µg 1 2 3 4 5 Total
Pregnancy Rates - Palpation Data
  0 35/68 14/29 14/28 3/20 20/56 86/201
(51.5) (48.3) (50.0) (15.0) (35.7) (42.8)
100 33/66 17/27 12/25 13/21 25/58 100/197
(50.0) (63.0) (48.0) (61.9) (43.1) (50.8)a
200 41/67 18/30 14/27 9/23 18/56 100/203
(61.2) (60.0) (51.9) (39.1) (32.2) (49.3)
Pregnancy Rates - Calving Data
  0 13/29 11/19 24/48
(44.8) (57.9) (50.0)
100 18/27 13/20 31/47
(66.7) (65.0) (66.0)b
200 19/30 15/22 34/52
(63.3) (68.2) (65.4)b
Injection of fertirelin acetate was given (i.m.) once on d 11-14 after estrus (d 0) and insemination.1
Different (P<.08) from control (0 µg) dose.a
Different (P=.11) from control (0 µg) dose.b
Table 2. Pregnancy Rates (%) in Suckled Beef Cows Based on Palpation of the Uterus (45
to 80 d) and Actual Calving Dates1
Location
Dose, µg 1 2 Total
Pregnancy Rates - Palpation Data
  0 21/29 15/22 36/51
(72.4) (68.2) (70.6)
100 17/21 13/22 30/43
(81.0) (59.0) (69.8)
200 20/25 14/26 34/51
(80.0) (53.8) (66.7)
Pregnancy Rates - Calving Data
  0 20/27 10/14 30/41
(74.1) (71.4) (73.2)
100 18/21 14/15 32/36
(85.7) (93.3) (88.9)a
200 17/22 14/16 31/38
(77.3) (87.5) (81.6)
Injection of fertirelin acetate was given (i.m.) once on d 11-14 after estrus (d 0) and insemination.1
Different (P=.08) from control (0 µg) dose.a
